Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares) (CCM): Price and Financial Metrics
GET POWR RATINGS... FREE!
CCM Stock Summary
- Equity multiplier, or assets relative to shareholders' equity, comes in at -5.69 for CONCORD MEDICAL SERVICES HOLDINGS LTD; that's greater than it is for only 2.62% of US stocks.
- Revenue growth over the past 12 months for CONCORD MEDICAL SERVICES HOLDINGS LTD comes in at 171.6%, a number that bests 94.8% of the US stocks we're tracking.
- CONCORD MEDICAL SERVICES HOLDINGS LTD's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -349.43%, greater than the shareholder yield of only 1.29% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to CONCORD MEDICAL SERVICES HOLDINGS LTD, a group of peers worth examining would be WW, LESL, HZN, CURV, and BBWI.
- CCM's SEC filings can be seen here. And to visit CONCORD MEDICAL SERVICES HOLDINGS LTD's official web site, go to www.concordmedical.com.
CCM Stock Price Chart Interactive Chart >
CCM Price/Volume Stats
| Current price | $1.60 | 52-week high | $2.38 |
| Prev. close | $1.63 | 52-week low | $1.15 |
| Day low | $1.60 | Volume | 400 |
| Day high | $1.60 | Avg. volume | 3,103 |
| 50-day MA | $1.64 | Dividend yield | N/A |
| 200-day MA | $1.79 | Market Cap | 69.67M |
Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares) (CCM) Company Bio
Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company was founded in 2007 and is based in Beijing, China.
Latest CCM News From Around the Web
Below are the latest news stories about CONCORD MEDICAL SERVICES HOLDINGS LTD that investors may wish to consider to help them evaluate CCM as an investment opportunity.
Concord Medical Schedules 2022 Annual Meeting of ShareholdersConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2022 annual general meeting of shareholders (the "Meeting") on December 30, 2022, at 10:00 a.m. (Beijing Time). The meeting will be held |
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD AndersonConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced the successful holding of the Second Annual Academic Meeting (the "Meeting") jointly by Shanghai Concord Cancer Center and The University of Texas MD Anderson |
Concord Medical Announces Changes in ManagementConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced changes in its management. |
Concord Medical Reports Financial Results for the First Half of 2022Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2022[1]. |
Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong LimitedConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that its subsidiary, Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a company incorporated in China, filed an application (the "Application") to l |
CCM Price Returns
| 1-mo | -4.19% |
| 3-mo | -19.19% |
| 6-mo | -8.57% |
| 1-year | -26.94% |
| 3-year | -38.29% |
| 5-year | -56.28% |
| YTD | -20.00% |
| 2021 | -27.01% |
| 2020 | 2.71% |
| 2019 | -25.06% |
| 2018 | 6.91% |
| 2017 | -27.61% |
Continue Researching CCM
Here are a few links from around the web to help you further your research on Concord Medical Services Holdings Ltd's stock as an investment opportunity:Concord Medical Services Holdings Ltd (CCM) Stock Price | Nasdaq
Concord Medical Services Holdings Ltd (CCM) Stock Quote, History and News - Yahoo Finance
Concord Medical Services Holdings Ltd (CCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...